Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.
Bipolar Disord
; 25(3): 233-244, 2023 05.
Article
in En
| MEDLINE
| ID: mdl-36636839
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bipolar Disorder
/
Depressive Disorder, Treatment-Resistant
/
Ketamine
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Bipolar Disord
Journal subject:
PSIQUIATRIA
Year:
2023
Type:
Article
Affiliation country:
Italy